For the control of estrogen-responsive urinary incontinence in ovariohysterectomized female dogs
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORE